Niigata Cancer Center Hospital

Niigata, Niigata 951-8566

1 studies enrolling now · 3 studies all time

What they study most

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer

Studies at this site

• Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations — Recruiting now
• Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer — Completed
• BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation — Completed